1-8 of 8
Mu Hao, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Hierarchical Prognostic Model Based on Clinical Feature and Cytogenetics for Splenic Marginal Zone Lymphoma

Yuting Yan, Wenjie Xiong, Shuhua Yi, MD, PhD, Rui Lv, MD, PhD, Zhen Yu, Wei Liu, MD,PhD, Heng Li, Huimin Liu, Zengjun Li, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2016) 128 (22): 1808.
https://doi.org/10.1182/blood.V128.22.1808.1808
Published: 2016
Journal Articles

The Addition of Novel Agents to Front-Line Therapy Significantly Improve the Short-Term and Long-Term Therapeutic Effects of High Risk Waldenstrom's Macroglobulinemia Patients in China

Wenjie Xiong, Shuhua Yi, MD, PhD, Heng Li, Zengjun Li, MD, PhD, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Yan Xu, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2016) 128 (22): 5333.
https://doi.org/10.1182/blood.V128.22.5333.5333
Published: 2016
Journal Articles

The Clinical Features and Prognosis of Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia: A Large Series Analysis from a Single Center

Wenjie Xiong, Shuhua Yi, MD, PhD, Heng Li, Zengjun Li, MD, PhD, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Yan Xu, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2016) 128 (22): 5334.
https://doi.org/10.1182/blood.V128.22.5334.5334
Published: 2016
Journal Articles

Plasma Cell Leukemia in China: Retrospective Analysis of Clinical Characteristics and Prognosis

Tengteng Yu, MD, Yan Xu, MD, PhD, Gang An, MD PhD, Zengjun Li, MD, PhD, Mu Hao, MD, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2016) 128 (22): 5619.
https://doi.org/10.1182/blood.V128.22.5619.5619
Published: 2016
Journal Articles

PHF19 Promotes Drug Resistance through EZH2 Inactivation in Multiple Myeloma

Tengteng Yu, MD, Lanting Liu, Shuaishuai Zhang, MD, Mu Hao, MD,PhD, Lugui Qiu, MD
Journal: Blood
Blood (2016) 128 (22): 4495.
https://doi.org/10.1182/blood.V128.22.4495.4495
Published: 2016
Journal Articles

Serum High Expression of Micorna-214 Is a Novel Predictor for Myeloma Bone Disease and Poor Prognosis

Mu Hao, MD PhD, Meirong Zang, PhD, Yan Xu, MDPhD, Yu Qin, MD PhD, Lei Zhao, MD PhD, Shuhui Deng, MD PhD, Weiwei Sui, MD, Gang An, MDPhD, Zengjun Li, MD PhD, Yi Shuhua, MD PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4186.
https://doi.org/10.1182/blood.V126.23.4186.4186
Published: 2015
Journal Articles

Drug Resistant Myeloma Cells Cause More Severe Bone Destruction in Myeloma

Mu Hao, MD PhD, Zhimin Gu, PhD, Reinaldo Franqui Machin, Hongwei Xu, Gregory S. Thomas, PhD, Lugui Qiu, MD PhD, Guido J Tricot, MD PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 839.
https://doi.org/10.1182/blood.V126.23.839.839
Published: 2015
Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2480.
https://doi.org/10.1182/blood.V126.23.2480.2480
Published: 2015